Loading [Contrib]/a11y/accessibility-menu.js

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
JHEOR
  • Menu
  • Articles
    • Author Correction
    • Autoimmune Diseases
    • Brief Report
    • Cardiovascular Conditions
    • Commentary
    • Correspondence
    • Dermatological Diseases
    • Endocrinology
    • Gastrointestinal Conditions
    • General Indications
    • Genetic Disorders
    • Hematology
    • Infectious Diseases
    • Methodology and Healthcare Policy
    • Musculoskeletal Conditions
    • Nephrologic/Hepatologic Conditions
    • Neurological Disorders
    • Oncology
    • Ophthalmology
    • Other Conditions
    • Perspective
    • Psychological Conditions
    • Respiratory Diseases
    • Trauma Induced Conditions
    • Urological/Gynecological Diseases
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Journal Policies
  • For Reviewers
  • search
  • X (formerly Twitter) (opens in a new tab)
  • Bluesky (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:4849/feed
ISSN 2327-2236
Cardiovascular Conditions
Vol. 3, Issue 1, 2015October 26, 2016 EDT

Cost-effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective

Yaariv Khaykin, Peter J. Mallow, John A. Rizzo, Atul Verma, Lauren Chun, Shelby Olesovsky, Matthew R. Reynolds,
markov modelcost-utilitycanadaatrial fibrillationcost-effectiveness
Copyright Logoccby-4.0 • https://doi.org/10.36469/9837

Articles in Vol. 3, Issue 1, 2015

Vol. 3, Issue 1, 2015
  • Cost-effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective
    Yaariv KhaykinPeter J. MallowJohn A. RizzoAtul VermaLauren ChunShelby OlesovskyMatthew R. Reynolds
  • Economic Impact of Changes in Neonatal Intensive Care Unit Ventilation Strategies with the Advent of New Noninvasive Ventilation Techniques: A Review and Proposed Assessment Framework for High Flow Therapy as a Routine Respiratory Support Paradigm
    Jan B. PietzschAbigail M. GarnerMichael McQueen
  • The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need
    Pierre-Alexandre DionneFarzad AliMendel Grobler
  • System Dynamics Modeling Can be Leveraged to Predict Critical Care Pathways and Costs for End Stage Renal Disease: US Population to 2020
    Luca FernandezChristopher KolibaAsim ZiaKatharine CheungRichard SolomonChristopher Jones
  • Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian Claims Data
    Adrian WaggDemitri DilesTodd Berner
  • Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
    Emuella FloodKavita GajriaVanja SikiricaPaul HodgkinsM. Haim ErderFrank LopezDaniel Connor
  • The Direct Healthcare Expenditures of Prostate Cancer by Disease Severity: Evidence from US National Survey Data
    Peter J. MallowJie ChenJohn A. RizzoJohn R. PenrodGeralyn C. TrudelTeresa M. Zyczynski
  • The Impact of Endoscopic Linear Stapling Device Stability in Thoracic Surgery: A Delphi Panel Approach
    Daniel MillerDiego Gonzalez RivasKellie L. MeyerRyan S. ClarkTadasu Kohno
  • Medicaid Eligibility and Time to Re-incarceration Among Previously Incarcerated Subjects With Schizophrenia
    Chris KozmaMichael DicksonJacqueline PesaCarmela J. Benson
  • Effectiveness of a Patient Support Program in Supporting Access to Therapy for Solid Tumor Malignancies
    Lindsay ParkerAlissa ShaulBrian MurphyZeba M. Khan
JHEOR
1.
Khaykin Y, Mallow PJ, Rizzo JA, et al. Cost-effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective. JHEOR. 2016;3(1):1-12. doi:10.36469/9837
Save article as...▾

View more stats

Powered by Scholastica, the modern academic journal management system